SVIX Q2: Massive VIX futures losses cut NAV to $15.57; $48.5M quarterly operating loss

VS Trust (NYSEARCA: SVIX) - Q2 2025 snapshot (‑1x Short VIX Futures ETF)

Quick facts & position
* Total Assets (June 30, 2025): $269,584,064
* Net Assets (June 30, 2025): $268,947,186
* Shares Outstanding: 17,270,000
* NAV per share (June 30, 2025): $15.57 - Market value per share: $15.51
* Cash / collateral held (pledged for futures/options): $176,802,487 (included in "Other Assets in Excess of Liabilities")
* Management fee: 1.35% per annum (SVIX)
* Expense ratio (quarter): 1.54% - (six months): 1.58%

Income-statement positives
* Interest income (Q2 2025): $2,385,094 (six months: $3,790,120) - meaningful cash yield from money‑market holdings.
* Net investment income (Q2 2025): $671,652 (six months: $1,024,214) - the fund generated positive investment income after expenses.
* Strong capital activity: net capital inflows during the quarter from creations (shares sold 59,980,000) exceeded redemptions, producing a net capital increase of $29,571,282 for the quarter and $49,534,882 for six months - shows investor demand/secondary market liquidity.

Income-statement negatives / risks
* Derivatives losses dominate operational results: Net realized & unrealized loss on investments and futures contracts (Q2 2025): $(49,182,348); net decrease in net assets from operations (Q2 2025): $(48,510,696). Six months: realized & unrealized loss $(81,735,733); operations $(80,711,519).
* Large realized futures loss in the quarter: futures realized loss $(71,701,776) (options realized loss $(1,965,313)). These are concentrated, large swings tied to VIX futures positions.
* NAV erosion: NAV per share fell from $20.32 at period start to $15.57 at quarter end (quarter total return at NAV: ‑23.38%; six‑month total return at NAV: ‑38.68%).
* High leverage and compounding risk: fund targets daily inverse exposure (‑1x) to a VIX futures index - performance over multi‑day periods can diverge materially from the benchmark due to daily rebalancing and volatility.
* Expense profile: effective costs are non‑trivial for a niche, active derivatives fund (expense ratio ~1.5% and additional trading / futures account fees).
* Net assets declined vs. beginning of period ($300,123,823 → $268,947,186) despite inflows, because trading losses outpaced investment income and inflows.

What's happening inside the fund (operational view)
* The Fund holds cash/money market instruments as collateral and uses large VIX futures positions for target inverse exposure - deposits at broker for futures/options: $176,802,487 (June 30, 2025).
* Active daily rebalancing produced significant realized losses this period as futures moved against the fund's short exposure; unrealized futures gains partly offset but not enough.
* Sponsor (Volatility Shares LLC) is the commodity pool operator; SVIX is structured to deliver a daily inverse return and explicitly warns that it's unsuitable for buy‑and‑hold investors.
* Fund remains an emerging growth company and continues standard third‑party agreements (U.S. Bank custodian/admin, Foreside marketing agent).

Key metrics to watch next
* Weekly/daily VIX futures curve movements (contango/backwardation) - roll costs drive performance.
* Size and direction of futures exposures (notional) and margin/deposits - large notional swings drove these losses.
* Net flows vs. trading P/L - inflows can't offset sustained trading losses indefinitely.
* Expense ratio and trading costs evolution - higher trading volumes and rebalances increase frictional costs.

Bottom line
VS Trust's SVIX produced positive investment income and attracted capital in Q2 2025, but the fund suffered large realized and unrealized losses from its VIX futures positions that drove a substantial drop in NAV ($15.57 at quarter end) and an operating loss of $(48,510,696) for the quarter (six months $(80,711,519)). This is a high‑risk, daily‑rebalanced inverse volatility product: short‑term income/liquidity looks healthy, but derivatives exposure and compounding/leverage effects created significant negative operating performance. Investors should treat SVIX as a tactical, short‑horizon instrument and monitor futures notional, roll costs and margin dynamics closely.